Goldhaber S Z
Harvard University, Harvard Medical School, Boston.
Hosp Pract (Off Ed). 1991 Sep 15;26(9):37-48. doi: 10.1080/21548331.1991.11705291.
Although morbidity and mortality remain high, we now have effective strategies to prevent development of the disease in many patients at risk. For those who do not benefit from prophylaxis, our understanding of optimal diagnostic strategy has improved, as has that of classic anticoagulation therapy with heparin and warfarin. Thrombolysis may also improve outcome.
